NFKB1 and non-small cell lung carcinoma: Accumulating evidence in vitro and in vivo supports the fact that the activation of TLR4 and the downstream myd88/NF-κB/MMP2 axis via signaling pathways contribute to NSCLC metastasis [21, 23].